Nascent Biotech, Inc. Stock
Stocks
NBIO
US63108Q1013
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
OTC Markets
20:38:59 26/05/2026 +03
|
5-day change | 1st Jan Change | ||
| 0.000300 USD | -.--% |
|
+50.00% | -50.00% |
| 14/08/24 | Nascent Biotech, Inc. Reports Earnings Results for the First Quarter Ended June 30, 2024 | CI |
| 02/07/24 | Nascent Biotech, Inc. Reports Earnings Results for the Full Year Ended March 31, 2024 | CI |
| Market Cap | 1.12M 1.01M 930K 843K 1.57M 107M 1.59M 11.13M 4.43M 55.98M 4.21M 4.13M 177M | P/E 2023 |
-2.38x | P/E 2024 | -13.8x |
|---|---|---|---|---|---|
| Enterprise Value | 874K 784K 723K 656K 1.22M 83.2M 1.24M 8.66M 3.45M 43.54M 3.28M 3.21M 138M | EV / Sales 2023 |
-
| EV / Sales 2024 | - |
| Free-Float |
78.49% | Yield 2023 * |
-
| Yield 2024 | - |
| 1 week | +50.00% | ||
| Current month | +50.00% | ||
| 1 month | +50.00% | ||
| 3 months | -50.00% | ||
| Current year | -50.00% |
| 1 month | 0 |  | 0 |
| Current year | 0 | | 0.08 |
| 1 year | 0 | | 0.13 |
| 3 years | 0 | | 0.28 |
| 5 years | 0 | | 0.45 |
| 10 years | 0 | | 0.77 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sean Carrick
CEO | Chief Executive Officer | 58 | 09/03/2015 |
Lowell Holden
DFI | Director of Finance/CFO | 83 | 01/05/2014 |
| Director | Title | Age | Since |
|---|---|---|---|
Lowell Holden
BRD | Director/Board Member | 83 | 15/07/2014 |
Sean Carrick
BRD | Director/Board Member | 58 | 15/07/2014 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 6/30/24 A | Others | Chief Operating Officer | 50,000 | 0.0295% | ||
| 6/30/24 A | Others | Chief Financial Officer | 96,000 | 0.0566% | ||
| 6/30/24 A | Others | Chief Executive Officer | 192,000 | 0.1131% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | +50.00% | -66.67% | -99.80% | 34.57K | |
| +0.65% | -3.56% | +33.53% | +60.50% | 63.48B | |
| +1.76% | +2.10% | +12.10% | +81.21% | 54.55B | |
| -0.94% | +0.77% | +8.85% | +100.19% | 53.59B | |
| +2.76% | +4.18% | +28.34% | +55.07% | 44.75B | |
| +2.00% | -2.90% | +18.37% | +119.04% | 41.62B | |
| +1.34% | -3.98% | +225.44% | +914.08% | 39.91B | |
| +0.64% | -3.85% | +11.71% | +45.57% | 32.47B | |
| +29.06% | +48.65% | +106.84% | +92.73% | 26.7B | |
| +3.72% | -7.45% | +24.25% | -2.99% | 23.36B | |
| Average | +4.10% | -0.38% | +40.28% | +136.56% | 38.04B | |
| Weighted average by Cap. | +3.23% | -0.29% | +47.56% | +161.47% |
| 2023 | 2024 | |
|---|---|---|
| Net sales | - | - |
| Net income | -2.8M -2.51M -2.32M -2.1M -3.92M -267M -3.97M -27.74M -11.05M -140M -10.51M -10.29M -442M | -2.09M -1.87M -1.73M -1.57M -2.92M -199M -2.96M -20.68M -8.24M -104M -7.83M -7.67M -329M |
| Net Debt | 217K 195K 180K 163K 304K 20.7M 308K 2.15M 858K 10.83M 816K 799K 34.3M | -250K -224K -207K -187K -349K -23.77M -354K -2.47M -985K -12.44M -936K -917K -39.38M |
Employees
-
- Stock Market
- Stocks
- NBIO Stock
Select your edition
All financial news and data tailored to specific country editions
